Ivermectin is a versatile antiparasitic agent widely used in various compounded formulations to treat a range of parasitic infections. It works by binding to glutamate-gated chloride ion channels in the nerve and muscle cells of parasites, leading to increased permeability of the cell membrane to chloride ions, resulting in paralysis and death of the parasite. This mechanism makes ivermectin effective against a broad spectrum of parasites, including nematodes and arthropods.

In addition to its antiparasitic properties, ivermectin has been explored for its potential antiviral and anti-inflammatory effects, which have garnered interest in the medical community. Its safety profile is well-established, with a long history of use in both human and veterinary medicine. Ivermectin is typically well-tolerated, with side effects being rare and usually mild, such as dizziness or gastrointestinal discomfort.

Due to its efficacy and safety, ivermectin is often included in compounded formulations tailored to meet specific patient needs, offering flexibility in dosing and administration. This adaptability is particularly beneficial in cases where standard treatments are ineffective or contraindicated. As a result, ivermectin remains a valuable component in the arsenal of treatments available to healthcare providers, ensuring comprehensive care for patients with parasitic infections.